Inoperable stage III EGFR mutant non-small-cell lung cancer: time for drug first, local later?
Ann Oncol
.
2024 Dec;35(12):1074-1076.
doi: 10.1016/j.annonc.2024.10.005.
Epub 2024 Oct 11.
Authors
A John
1
,
F McDonald
2
,
S Popat
3
Affiliations
1
Lung Unit, Royal Marsden Hospital, London, UK. Electronic address: https://twitter.com/DrAlexiusJ.
2
Lung Unit, Royal Marsden Hospital, London, UK; Institute of Cancer Research, London, UK. Electronic address: https://twitter.com/fifimcdrmh.
3
Lung Unit, Royal Marsden Hospital, London, UK; Institute of Cancer Research, London, UK. Electronic address: sanjay.popat@rmh.nhs.uk.
PMID:
39395537
DOI:
10.1016/j.annonc.2024.10.005
No abstract available
Publication types
Editorial